1. EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
    Bohan Wang et al, 2023, Experimental Hematology & Oncology CrossRef
  2. Immuohistochemical expression and significance of NADPH oxidase 1 and CXCR4 in hepatitis C virus-induced hepatocellular carcinoma
    Marwa S. Abd Allah et al, 2018, Egyptian Journal of Pathology CrossRef
  3. Cancer Stem Cells as a Seed for Cancer Metastasis
    L. Lizha Mary et al, 2020, Cancer Stem Cells: New Horizons in Cancer Therapies CrossRef
  4. Xiaoaiping injection affects the invasion and metastasis of hepatocellular carcinoma by controlling AFP expression
    Shu Huang et al, 2023, Oncology and Translational Medicine CrossRef
  5. Insights Into the Somatic Mutation Burden of Hepatoblastomas From Brazilian Patients
    Talita Ferreira Marques Aguiar et al, 2020, Frontiers in Oncology CrossRef
  6. Systems biology investigation of epithelial-mesenchymal transition in hepatocellular carcinoma pathogenesis
    Fatemeh karimpour et al, 2023, Informatics in Medicine Unlocked CrossRef
  7. JMJD3 promotes the epithelial‑mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis
    Shuang Zou et al, 2019, Oncology Letters CrossRef
  8. High co-expression of the SDF1/CXCR4 axis in hepatocarcinoma cells is regulated by AnnexinA7 in vitro and in vivo
    Jingwen Wang et al, 2018, Cell Communication and Signaling CrossRef
  9. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer
    Ping Yang et al, 2020, Current Medicinal Chemistry CrossRef
  10. Copy Number Alterations in Hepatoblastoma: Literature Review and a Brazilian Cohort Analysis Highlight New Biological Pathways
    Juliana Sobral Barros et al, 2021, Frontiers in Oncology CrossRef
  11. Development of a Chemoresistant Risk Scoring Model for Prechemotherapy Osteosarcoma Using Single-Cell Sequencing
    Ziliang Zeng et al, 2022, Frontiers in Oncology CrossRef
  12. Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
    Khaled S. Allemailem et al, 2022, Cancer Communications CrossRef
  13. CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections
    Ulyana I. Bartosh et al, 2023, International Journal of Molecular Sciences CrossRef
  14. Nucleotide Aptamers as Theranostic Biomaterials
    Yuezhou Zhang et al, 2019, Theranostic Bionanomaterials CrossRef
  15. Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine
    Narges Jokar et al, 2022, Clinical and Translational Imaging CrossRef